Beck O A, Ihle C, Hochrein H
Dtsch Med Wochenschr. 1982 Apr 16;107(15):579-83. doi: 10.1055/s-2008-1069980.
The anti-arrhythmic effectiveness of propafenon (3 x 150 mg daily) combined with propranolol (3 x 20 mg daily) was compared with that of each drug alone in 15 patients with stable ventricular and (or) supraventricular extrasystoles. The frequency of extrasystoles decreased on propafenon alone by 70% (P less than 0.05), without further decrease on additional propranolol administration. Propranolol alone on average caused no significant decrease infrequency (35%). The most important ECG changes with the combined treatment consisted of a definite increase in P-Q interval by an average of 25% (P less than 0.01) while with propafenon alone it was 13%, with propranolol alone 19% . Propafenon plus propranolol decreased heart rate by a mean of 17% (P less than 0.01). The additive effect of both substances can lead to an inhibition of atrioventricular conduction and of sinus node function.
在15例患有稳定室性和(或)室上性期前收缩的患者中,比较了普罗帕酮(每日3次,每次150毫克)联合普萘洛尔(每日3次,每次20毫克)与单独使用每种药物的抗心律失常效果。单独使用普罗帕酮时,期前收缩频率降低了70%(P<0.05),额外给予普萘洛尔后未进一步降低。单独使用普萘洛尔平均未使频率显著降低(35%)。联合治疗最重要的心电图变化包括P-Q间期平均明确增加25%(P<0.01),而单独使用普罗帕酮时为13%,单独使用普萘洛尔时为19%。普罗帕酮加普萘洛尔使心率平均降低17%(P<0.01)。两种药物的相加作用可导致房室传导和窦房结功能受到抑制。